10.23.2018 Issue 424

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

ICER Mulls Biopharma Evaluation Program

Wednesday, October 17

ICER is considering a new program to help biopharmaceutical companies with early clinical reviews, which could open the door to a new funding paradigm for the organization, the Regulatory Affairs Professional Society reports.

Executives Talk Blockchain, EMR with Value & Outcomes

Quinn Looks at CMS’ Justification of Authority for Drug Prices in Ads

Partnership of Hospitals Targets High Drug Prices

PhRMA CEO Talks DTC Advertising

Coalition of Research Funders Push for Open Access

Birth of ‘Journalology’ Looked to Establish Evidence-Based Protocol for Publications

Navigating High Insulin Costs

Report: Times Vary Widely on Reimbursement Decisions for New Cancer Drugs in EU


Health Economics and Outcomes Associate Consultant

Research Data Assistant or Research Data Coordinator-PS8373

Research Associate III- Patient-Centered Research- Hammersmith

Healthcare Software Product Manager

Health Economist

Lead Health Economist

Associate Director Health Economics

Associate Director/ Director, Medical Affairs- HEOR

Industry Spotlight


Conferences Webinars
MedTech Reimbursement Summit
    October 24-25, Dallas, Texas

Partners in Digital Health
    October 24, New York, New York

Antimicrobial Resistance Congress
    October 25-26, Washington, D.C.

Real-world Data and Life Science Analytics Congress
    October 25, Boston, Massachusetts

Clinical Pathways Congress
    October 26-28, Boston, Massachusetts

Drug Pricing Policy: What's on the Horizon?
    October 23

3-Hour Virtual Seminar on MACRA and MIPS - HIPAA Rules for Text Messaging and Email
    October 23

Securing Endpoint Devices Against Unauthorized Access
    October 23

Creating Value: A Framework for Analytics-Driven Performance Improvement
    October 25


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Health Care USA: A Cancer on the American Dream

The Utility of ICER Reports for Private Payer Drug Coverage Decision-Making: Cost-Effectiveness Assessments

Advancing Biosimilar Sustainability in Europe

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment


 
Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL  Xcenda
        OM1Parexel   Jefferson   Dymaxium   Precision Xtract
          Pharmerit    eMax Health   SciformixEvidence Partners
          ICON    Truven